Penetrex
Commercial- Indications
- Joint pain, Muscle pain
Company intelligence / Profile preview
Carlin Consumer Health is a private equity-backed consumer health business focused on acquiring and commercializing leading over-the-counter brands. Since its founding in 2022, it has acquired several established OTC brands including Zegerid OTC for heartburn treatment from Bayer, Mylanta and Mylicon for digestive health via the acquisition of Infirst USA Holdings, and Penetrex for joint/muscle care from Wellbeam Consumer Health. The company is actively expanding its portfolio through further acquisitions.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carlin Consumer Health.